Multimodal dopaminergic and free-water imaging in Parkinson's disease

Jing Yang, Derek B. Archer, Roxana G. Burciu, Martijn L.T.M. Müller, Arnab Roy, Edward Ofori, Nicolaas I. Bohnen, Roger L. Albin, David E. Vaillancourt

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Introduction: When using free-water diffusion imaging or positron emission tomography (PET), it is established that substania nigra microstructure and presynaptic dopamine activity are impaired in early PD. It is not well understood if these two forms of degeneration are redundant, or if they each provide a unique contribution to the clinical motor and cognitive symptoms. Methods: A total of 129 PD and 75 control individuals underwent motor and cognitive evaluations, and in vivo [11C]dihydrotetrabenazine (DTBZ) monoaminergic brain PET imaging and diffusion imaging. Correlations between free-water in the substantia nigra and striatal PET measures were analyzed. Unbiased multiple regression using a backward elimination method was performed between clinical severity and all imaging measures. Results: Inverse correlations were found between free-water in posterior substantia nigra and DTBZ binding in putamen and caudate. Multiple regression revealed that increased free-water in the posterior substantia nigra, decreased DTBZ binding in putamen, and age were predictors of higher Hoehn and Yahr stage, MDS-UPDRS III scores, and posture and gait sub-scores. Increased posterior substantia nigra free-water alone was associated tremor scores. Free-water in caudate and putamen did not predict measures of motor performance. Decreased DTBZ binding in caudate, increased free-water in caudate and posterior substantia nigra were associated with higher dementia ratings. Conclusions: These findings suggest that free-water in the posterior substantia nigra and presynaptic dopamine imaging in striatum are uniquely associated with the clinical symptoms of PD, indicating that each imaging modality may be measuring a unique mechanism relevant to nigrostriatal degeneration.

Original languageEnglish (US)
Pages (from-to)10-15
Number of pages6
JournalParkinsonism and Related Disorders
Volume62
DOIs
StatePublished - May 2019

Fingerprint

Parkinson Disease
Substantia Nigra
Water
Putamen
Positron-Emission Tomography
Dopamine
Corpus Striatum
Neurobehavioral Manifestations
Tremor
Posture
Gait
Dementia
dihydrotetrabenazine
Brain

Keywords

  • Basal ganglia
  • Diffusion magnetic resonance imaging
  • Multimodal imaging
  • Parkinson's disease
  • PET
  • Substantia nigra

ASJC Scopus subject areas

  • Neurology
  • Geriatrics and Gerontology
  • Clinical Neurology

Cite this

Yang, J., Archer, D. B., Burciu, R. G., Müller, M. L. T. M., Roy, A., Ofori, E., ... Vaillancourt, D. E. (2019). Multimodal dopaminergic and free-water imaging in Parkinson's disease. Parkinsonism and Related Disorders, 62, 10-15. https://doi.org/10.1016/j.parkreldis.2019.01.007

Multimodal dopaminergic and free-water imaging in Parkinson's disease. / Yang, Jing; Archer, Derek B.; Burciu, Roxana G.; Müller, Martijn L.T.M.; Roy, Arnab; Ofori, Edward; Bohnen, Nicolaas I.; Albin, Roger L.; Vaillancourt, David E.

In: Parkinsonism and Related Disorders, Vol. 62, 05.2019, p. 10-15.

Research output: Contribution to journalArticle

Yang, J, Archer, DB, Burciu, RG, Müller, MLTM, Roy, A, Ofori, E, Bohnen, NI, Albin, RL & Vaillancourt, DE 2019, 'Multimodal dopaminergic and free-water imaging in Parkinson's disease', Parkinsonism and Related Disorders, vol. 62, pp. 10-15. https://doi.org/10.1016/j.parkreldis.2019.01.007
Yang, Jing ; Archer, Derek B. ; Burciu, Roxana G. ; Müller, Martijn L.T.M. ; Roy, Arnab ; Ofori, Edward ; Bohnen, Nicolaas I. ; Albin, Roger L. ; Vaillancourt, David E. / Multimodal dopaminergic and free-water imaging in Parkinson's disease. In: Parkinsonism and Related Disorders. 2019 ; Vol. 62. pp. 10-15.
@article{8fe5d22a73a84409b8c4a643833f688a,
title = "Multimodal dopaminergic and free-water imaging in Parkinson's disease",
abstract = "Introduction: When using free-water diffusion imaging or positron emission tomography (PET), it is established that substania nigra microstructure and presynaptic dopamine activity are impaired in early PD. It is not well understood if these two forms of degeneration are redundant, or if they each provide a unique contribution to the clinical motor and cognitive symptoms. Methods: A total of 129 PD and 75 control individuals underwent motor and cognitive evaluations, and in vivo [11C]dihydrotetrabenazine (DTBZ) monoaminergic brain PET imaging and diffusion imaging. Correlations between free-water in the substantia nigra and striatal PET measures were analyzed. Unbiased multiple regression using a backward elimination method was performed between clinical severity and all imaging measures. Results: Inverse correlations were found between free-water in posterior substantia nigra and DTBZ binding in putamen and caudate. Multiple regression revealed that increased free-water in the posterior substantia nigra, decreased DTBZ binding in putamen, and age were predictors of higher Hoehn and Yahr stage, MDS-UPDRS III scores, and posture and gait sub-scores. Increased posterior substantia nigra free-water alone was associated tremor scores. Free-water in caudate and putamen did not predict measures of motor performance. Decreased DTBZ binding in caudate, increased free-water in caudate and posterior substantia nigra were associated with higher dementia ratings. Conclusions: These findings suggest that free-water in the posterior substantia nigra and presynaptic dopamine imaging in striatum are uniquely associated with the clinical symptoms of PD, indicating that each imaging modality may be measuring a unique mechanism relevant to nigrostriatal degeneration.",
keywords = "Basal ganglia, Diffusion magnetic resonance imaging, Multimodal imaging, Parkinson's disease, PET, Substantia nigra",
author = "Jing Yang and Archer, {Derek B.} and Burciu, {Roxana G.} and M{\"u}ller, {Martijn L.T.M.} and Arnab Roy and Edward Ofori and Bohnen, {Nicolaas I.} and Albin, {Roger L.} and Vaillancourt, {David E.}",
year = "2019",
month = "5",
doi = "10.1016/j.parkreldis.2019.01.007",
language = "English (US)",
volume = "62",
pages = "10--15",
journal = "Parkinsonism and Related Disorders",
issn = "1353-8020",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Multimodal dopaminergic and free-water imaging in Parkinson's disease

AU - Yang, Jing

AU - Archer, Derek B.

AU - Burciu, Roxana G.

AU - Müller, Martijn L.T.M.

AU - Roy, Arnab

AU - Ofori, Edward

AU - Bohnen, Nicolaas I.

AU - Albin, Roger L.

AU - Vaillancourt, David E.

PY - 2019/5

Y1 - 2019/5

N2 - Introduction: When using free-water diffusion imaging or positron emission tomography (PET), it is established that substania nigra microstructure and presynaptic dopamine activity are impaired in early PD. It is not well understood if these two forms of degeneration are redundant, or if they each provide a unique contribution to the clinical motor and cognitive symptoms. Methods: A total of 129 PD and 75 control individuals underwent motor and cognitive evaluations, and in vivo [11C]dihydrotetrabenazine (DTBZ) monoaminergic brain PET imaging and diffusion imaging. Correlations between free-water in the substantia nigra and striatal PET measures were analyzed. Unbiased multiple regression using a backward elimination method was performed between clinical severity and all imaging measures. Results: Inverse correlations were found between free-water in posterior substantia nigra and DTBZ binding in putamen and caudate. Multiple regression revealed that increased free-water in the posterior substantia nigra, decreased DTBZ binding in putamen, and age were predictors of higher Hoehn and Yahr stage, MDS-UPDRS III scores, and posture and gait sub-scores. Increased posterior substantia nigra free-water alone was associated tremor scores. Free-water in caudate and putamen did not predict measures of motor performance. Decreased DTBZ binding in caudate, increased free-water in caudate and posterior substantia nigra were associated with higher dementia ratings. Conclusions: These findings suggest that free-water in the posterior substantia nigra and presynaptic dopamine imaging in striatum are uniquely associated with the clinical symptoms of PD, indicating that each imaging modality may be measuring a unique mechanism relevant to nigrostriatal degeneration.

AB - Introduction: When using free-water diffusion imaging or positron emission tomography (PET), it is established that substania nigra microstructure and presynaptic dopamine activity are impaired in early PD. It is not well understood if these two forms of degeneration are redundant, or if they each provide a unique contribution to the clinical motor and cognitive symptoms. Methods: A total of 129 PD and 75 control individuals underwent motor and cognitive evaluations, and in vivo [11C]dihydrotetrabenazine (DTBZ) monoaminergic brain PET imaging and diffusion imaging. Correlations between free-water in the substantia nigra and striatal PET measures were analyzed. Unbiased multiple regression using a backward elimination method was performed between clinical severity and all imaging measures. Results: Inverse correlations were found between free-water in posterior substantia nigra and DTBZ binding in putamen and caudate. Multiple regression revealed that increased free-water in the posterior substantia nigra, decreased DTBZ binding in putamen, and age were predictors of higher Hoehn and Yahr stage, MDS-UPDRS III scores, and posture and gait sub-scores. Increased posterior substantia nigra free-water alone was associated tremor scores. Free-water in caudate and putamen did not predict measures of motor performance. Decreased DTBZ binding in caudate, increased free-water in caudate and posterior substantia nigra were associated with higher dementia ratings. Conclusions: These findings suggest that free-water in the posterior substantia nigra and presynaptic dopamine imaging in striatum are uniquely associated with the clinical symptoms of PD, indicating that each imaging modality may be measuring a unique mechanism relevant to nigrostriatal degeneration.

KW - Basal ganglia

KW - Diffusion magnetic resonance imaging

KW - Multimodal imaging

KW - Parkinson's disease

KW - PET

KW - Substantia nigra

UR - http://www.scopus.com/inward/record.url?scp=85059686023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059686023&partnerID=8YFLogxK

U2 - 10.1016/j.parkreldis.2019.01.007

DO - 10.1016/j.parkreldis.2019.01.007

M3 - Article

C2 - 30639168

AN - SCOPUS:85059686023

VL - 62

SP - 10

EP - 15

JO - Parkinsonism and Related Disorders

JF - Parkinsonism and Related Disorders

SN - 1353-8020

ER -